Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Biochimica Et Biophysica Acta. Reviews on Cancer
|
September 17, 2023
The dual role of citrate in cancer
Philippe Icard, Luca Simula, Grit Zahn, et al.
Investigative Ophthalmology & Visual Science
|
July 18, 2009
Integrin alpha5beta1 mediates attachment, migration, and proliferation in human retinal pigment epithelium: relevance for proliferative retinal disease
Rong Li, Arvydas Maminishkis, Grit Zahn, et al.
Chembiochem : a European Journal of Chemical Biology
|
May 16, 2008
Rational design of highly active and selective ligands for the alpha5beta1 integrin receptor
Dominik Heckmann, Axel Meyer, Burkhardt Laufer, et al.
Angewandte Chemie (International Ed. in English)
|
March 31, 2007
Probing integrin selectivity: rational design of highly active and selective ligands for the alpha5beta1 and alphavbeta3 integrin receptor
Dominik Heckmann, Axel Meyer, Luciana Marinelli, et al.
The Biochemical Journal
|
September 15, 2009
Mapping the ligand-binding pocket of integrin alpha5beta1 using a gain-of-function approach
A Paul Mould, Ewa J Koper, Adam Byron, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 5, 2009
SAR of N-phenyl piperidine based oral integrin alpha5beta1 antagonists
Gunther Zischinsky, Frank Osterkamp, Doerte Vossmeyer, et al.
Advances in Experimental Medicine and Biology
|
April 30, 2009
Highly selective cyclic hexapeptides antagonist of GPIIb-IIIa by multiple N-methylation
Jayanta Chatterjee, Oded Ovadia, Grit Zahn, et al.
Journal of Medicinal Chemistry
|
November 2, 2007
Multiple N-methylation by a designed approach enhances receptor selectivity
Jayanta Chatterjee, Oded Ovadia, Grit Zahn, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 14, 2009
Discovery of orally available integrin alpha5beta1 antagonists
Gunther Zischinsky, Frank Osterkamp, Doerte Vossmeyer, et al.
Therapeutic Advances in Rare Disease
|
August 2, 2024
The growing research toolbox for SLC13A5 citrate transporter disorder: a rare disease with animal models, cell lines, an ongoing Natural History Study and an engaged patient advocacy organization
Tanya L Brown, Matthew N Bainbridge, Grit Zahn, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Biochimica Et Biophysica Acta. Reviews on Cancer
|
September 17, 2023
The dual role of citrate in cancer
Philippe Icard, Luca Simula, Grit Zahn, et al.
Investigative Ophthalmology & Visual Science
|
July 18, 2009
Integrin alpha5beta1 mediates attachment, migration, and proliferation in human retinal pigment epithelium: relevance for proliferative retinal disease
Rong Li, Arvydas Maminishkis, Grit Zahn, et al.
Chembiochem : a European Journal of Chemical Biology
|
May 16, 2008
Rational design of highly active and selective ligands for the alpha5beta1 integrin receptor
Dominik Heckmann, Axel Meyer, Burkhardt Laufer, et al.
Angewandte Chemie (International Ed. in English)
|
March 31, 2007
Probing integrin selectivity: rational design of highly active and selective ligands for the alpha5beta1 and alphavbeta3 integrin receptor
Dominik Heckmann, Axel Meyer, Luciana Marinelli, et al.
The Biochemical Journal
|
September 15, 2009
Mapping the ligand-binding pocket of integrin alpha5beta1 using a gain-of-function approach
A Paul Mould, Ewa J Koper, Adam Byron, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 5, 2009
SAR of N-phenyl piperidine based oral integrin alpha5beta1 antagonists
Gunther Zischinsky, Frank Osterkamp, Doerte Vossmeyer, et al.
Advances in Experimental Medicine and Biology
|
April 30, 2009
Highly selective cyclic hexapeptides antagonist of GPIIb-IIIa by multiple N-methylation
Jayanta Chatterjee, Oded Ovadia, Grit Zahn, et al.
Journal of Medicinal Chemistry
|
November 2, 2007
Multiple N-methylation by a designed approach enhances receptor selectivity
Jayanta Chatterjee, Oded Ovadia, Grit Zahn, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 14, 2009
Discovery of orally available integrin alpha5beta1 antagonists
Gunther Zischinsky, Frank Osterkamp, Doerte Vossmeyer, et al.
Therapeutic Advances in Rare Disease
|
August 2, 2024
The growing research toolbox for SLC13A5 citrate transporter disorder: a rare disease with animal models, cell lines, an ongoing Natural History Study and an engaged patient advocacy organization
Tanya L Brown, Matthew N Bainbridge, Grit Zahn, et al.
Page
of 4